FDA Adverse Event Injury Summary report: N

LAP-BAND ADJUSTABLE GASTRIC BANDING SYSTEM (UNK SIZE)

MDR report key: 1895317 · Received November 2, 2010

Report

Report Number
2024601-2010-00930
Event Type
Injury
Date Received
November 2, 2010
Date of Event
September 18, 2009
Report Date
October 5, 2010
Manufacturer
ALLERGAN
Product Code
LTI
PMA / PMN Number
P000008
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
CI
Reporter Occupation
NO INFORMATION

Narratives

Additional Manufacturer Narrative · 1

TAPER UNK. (B)(4). THE REPORTER OF THE COMPLAINT WAS ASKED TO RETURN THE PRODUCT FOR ANALYSIS AS WELL AS INDICATE THE PRODUCT SERIAL NUMBER, DATE OF EVENT, IMPLANT DATE AND EXPLANT DATE. SINCE ALLERGAN HAS NOT YET RECEIVED THIS INFORMATION THE CONNECTOR TYPE CANNOT BE IDENTIFIED NOR AN ASSUMPTION MADE AS TO THE TYPE OF CONNECTOR ASSOCIATED WITH THIS COMPLAINT. VISUAL EXAMINATION MAY DETERMINE THE CONNECTOR TYPE. ALLERGAN HAS NOT RECEIVED THE PRODUCT AT THIS TIME. THEREFORE NO ANALYSIS OR TESTING HAS BEEN DONE. INFECTION IS A SURGICAL/PHYSIOLOGICAL COMPLICATION AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THIS EVENT. DEVICE LABELING ADDRESSES THE REPORTED EVENT OF INFECTION AS FOLLOWS: "INFECTION CAN OCCUR IN THE IMMEDIATE POST-OPERATIVE PERIOD OR YEARS AFTER INSERTION OF THE DEVICE. IN THE PRESENCE OF INFECTION OR CONTAMINATION, REMOVAL OF THE DEVICE IS INDICATED."

Description of Event or Problem · 1

DOCTOR REPORTED EVENTS OF "PORT INFECTION" FROM JOURNAL ARTICLE: "LAPAROSCOPIC ROUX-EN-Y GASTRIC BYPASS VERSUS LAPAROSCOPIC ADJUSTABLE GASTRIC BANDING: FIVE YEARS OF FOLLOW-UP", SURGERY FOR OBESITY AND RELATED DISEASES 6 (2010) 470-476. THIS MEDWATCH REPRESENTS THE 2 PATIENTS LISTED IN TABLE 3 ON PAGE 472 OF THIS ARTICLE WHO WERE DIAGNOSED WITH PORT INFECTION. ALLERGAN'S APPROACH TO COMPLIANCE IS TO RESOLVE ALL DOUBT IN FAVOR OF REPORTING.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 LAP-BAND ADJUSTABLE GASTRIC BANDING SYSTEM (UNK SIZE) LTI ALLERGAN NA NI

Patients

Seq Age Sex Outcome Treatment
1 NI Required Intervention